Orchestra BioMed (NASDAQ: OBIO)
$5.56
(-1.0%)
-$0.06
Price as of January 8, 2025, 1:02 p.m. ET
Orchestra BioMed Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Orchestra BioMed Company Info
Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded on May 25, 2020 and is headquartered in New Hope, PA.
News & Analysis
Featured Article
Why Shares of Orchestra BioMed Jumped Tuesday
The company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy.
Jim Halley | Sep 19, 2023
Featured Article
Why Shares of Orchestra BioMed Holdings Jumped Wednesday
The stock bounced back from hitting an all-time low the day before.
Jim Halley | Jun 28, 2023
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.